Skip to main content

Find Clinical Trials

Home
Conditions
Lymphoma, Large B-Cell, Diffuse

Clinical trial condition

Lymphoma, Large B-Cell, Diffuse

Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.

1,249 public trials 217 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Large B-Cell, Diffuse trial results

Completed

Dose Dense Chemotherapy and Rituximab for Young High Risk Diffuse Large B-Cell Lymphoma Patients (CRY-04)

NCT01502982

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Odense University Hospital Odense, Denmark

Helsinki University central Hospital Helsinki, Finland

Oslo University Hospital Oslo, Norway

Lund University Hospital Lund, Sweden

View Trial Details

Completed

Rituximab, Rasburicase, and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Advanced B-Cell Leukemia or Lymphoma

NCT00057811

Conditions: Burkitt Lymphoma, Childhood Burkitt Lymphoma, Childhood Diffuse Large Cell Lymphoma, +30 more
Locations: Children's Oncology Group Arcadia, California, United States

View Trial Details

Completed

EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer

NCT00004258

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +83 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

Rituximab After Autologous Stem Cell Transplant for Relapsed B-cell Non-Hodgkin's Lymphoma

NCT00225212

Conditions: Diffuse Large Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +14 more
Locations: Stanford University Medical Center Stanford, California, United States

View Trial Details

Completed

CT-011 MAb in DLBCL Patients Following ASCT

NCT00532259

Conditions: Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations: Moores UCSD Cancer Center La Jolla, California, United States

Scripps Cancer Center San Diego, California, United States

Emory University-Winship Cancer Institute Atlanta, Georgia, United States

Northside Hospital Atlanta, Georgia, United States

View all 27 locations

View Trial Details

Completed

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

NCT00589563

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Burkitt Lymphoma, +70 more
Locations: Banner Good Samaritan Medical Center Phoenix, Arizona, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

View Trial Details

Completed

Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors

NCT00003107

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +116 more
Locations: Indiana University Cancer Center Indianapolis, Indiana, United States

View Trial Details

Completed

A Structured Walking Program or Standard Therapy in Cancer Patients Undergoing a Donor Bone Marrow Transplant

NCT00445731

Conditions: Adnexal Diseases, Blast Crisis, Blood Protein Disorders, +96 more
Locations: Not specified

View Trial Details

Completed

Vorinostat and Decitabine in Treating Patients With Advanced Solid Tumors or Relapsed or Refractory Non-Hodgkin's Lymphoma, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, or Chronic Myelogenous Leukemia

NCT00275080

Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), +91 more
Locations: Chedoke-McMaster Hospitals Hamilton, Ontario, Canada

Juravinski Cancer Centre at Hamilton Health Sciences Hamilton, Ontario, Canada

Princess Margaret Hospital Phase 2 Consortium Toronto, Ontario, Canada

University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Completed

Study to Learn if 200mg Test Drug (Fostamatinib) Helps People With Large B-Cell Lymphoma,a Type of Blood Cancer

NCT01499303

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Research Site Huntsville, Alabama, United States

Research Site Denver, Colorado, United States

Research Site New Haven, Connecticut, United States

Research Site Sarasota, Florida, United States

View all 21 locations

View Trial Details